Revolution Medicines (RVMD) Capital Expenditures (2019 - 2026)
Revolution Medicines' Capital Expenditures was $2.29 million in Q2 2026, down 69.3% from $7.45 million a year earlier but up 48.6% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Capital Expenditures (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Revolution Medicines' Capital Expenditures was $9.1 million through Jun 30, 2026, down 41.1% year-over-year; for FY2025, it was $15.99 million, up 55.1% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 40.4% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $10.31 million in FY2024 (+33.4%), $7.73 million in FY2023 (-28.5%), $10.82 million in FY2022 (+65.7%) and $6.53 million in FY2021 (+122.6%).
- Quarterly Capital Expenditures has moved between $454,000 (Q3 2021) and $7.45 million (Q2 2025) over five years.
- Compared with a year earlier, Capital Expenditures was higher in four of the last eight quarters, with growth averaging 17.0%.
- The best year-over-year quarter for Capital Expenditures over five years was Q3 2022 (growth of 676.4%); the worst was Q2 2026 (a decline of 69.3%).
- Per Business Quant data, RVMD's Capital Expenditures in the three quarters before Q2 2026 was $1.54 million (Q1 2026), $1.93 million (Q4 2025) and $3.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 2.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.29 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 3.35 Mn |
| Jun 30, 2025 | 7.45 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 2.54 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 1.76 Mn |
| Dec 31, 2022 | 2.88 Mn |
| Sep 30, 2022 | 3.53 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 1.18 Mn |
| Sep 30, 2021 | 454,000.00 |
API Access
Revolution Medicines Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();